Impact of vitamin D replacement in adults and elderly in the Middle East and North Africa: a systematic review and meta-analysis of randomized controlled trials

被引:11
作者
Chakhtoura, M. [1 ]
Akl, E. A. [2 ]
El Ghandour, S. [2 ]
Shawwa, K. [2 ]
Arabi, A. [1 ]
Mahfoud, Z. [3 ]
Habib, R. H. [2 ]
Hoballah, H. [2 ]
Fuleihan, G. El Hajj [1 ]
机构
[1] Amer Univ, Beirut Med Ctr, WHO Collaborating Ctr Metab Bone Disorders, POB 113-6044-C8, Beirut, Lebanon
[2] Amer Univ, Dept Internal Med, Beirut Med Ctr, Beirut, Lebanon
[3] Weill Cornell Med, Dept Med Educ, Doha, Qatar
基金
美国国家卫生研究院;
关键词
Meta-analysis; Meta-regression; Middle East and North Africa; Vitamin D; TYPE-2; DIABETIC-PATIENTS; META-REGRESSION ANALYSIS; D SUPPLEMENTATION; CLINICAL-TRIAL; INSULIN-RESISTANCE; D DEFICIENCY; WOMEN; OVERWEIGHT; CALCIUM; MASS;
D O I
10.1007/s00198-016-3837-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the Middle East and North Africa (MENA), a vitamin D dose ae2000 IU/day may be needed to allow to the majority of the population to reach the target 25-hydroxyvitamin D (25(OH)D) level ae20 ng/ml. Data in the region on the effect of vitamin D supplementation on various skeletal and extra-skeletal effects are scarce. Hypovitaminosis D is prevalent worldwide, more so in the Middle East and North Africa (MENA). This study aims to determine the effects of vitamin D replacement on the mean difference in 25-hydroxyvitamin D [25(OH)D] level reached and other outcomes, in the MENA. This is a meta-analysis of randomized trials from the MENA, administering vitamin D supplementation for at least 3 months, without language or time restriction. We conducted a comprehensive search in seven databases until July 2015. We abstracted data from published reports, independently and in duplicate. We calculated the mean difference (MD) and 95 % CI of 25(OH)D level reached for eligible comparisons, and pooled data using RevMan version 5.3. We identified 2 studies in elderly and 17 in adults; for the latter, 11 were included in the meta-analysis. Comparing a high vitamin D dose (> 2000 IU/day) to placebo (nine studies), the MD in 25(OH)D level achieved was 18.3 (CI 14.1; 22.5) ng/ml; p value < 0.001; I (2) = 92 %. Comparing an intermediate dose (800-2000 IU/day) to placebo (two studies), the MD in 25(OH)D level achieved was 14.7 (CI 4.6; 24.9) ng/ml; p value 0.004; I (2) = 91 %. Accordingly, 89 and 71 % of participants, in the high and intermediate dose groups, respectively, reached the desirable level of 20 ng/ml. The risk of bias in the included studies was unclear to high, except for three studies. In the MENA region, vitamin D doses ae2000 IU/day may be needed to reach the target 25(OH)D level ae20 ng/ml. The long-term safety and the efficacy of such doses on various outcomes are unknown.
引用
收藏
页码:35 / 46
页数:12
相关论文
共 43 条
  • [1] Ahmadi N, 2013, J RES MED SCI, V18, P374
  • [2] Effect of Vitamin D Supplementation on Glucose Control and Inflammatory Response in Type II Diabetes: A Double Blind, Randomized Clinical Trial
    Al-Sofiani, Mohammed E.
    Jammah, Anwar
    Racz, Michael
    Khawaja, Rajab A.
    Hasanato, Rana
    El-Fawal, Hassan A. N.
    Mousa, Shaker A.
    Mason, Darius L.
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2015, 13 (01)
  • [3] Al-Zahrani MK, 2014, INT J CLIN EXP MED, V7, P5421
  • [4] [Anonymous], 2014, EFFECTS DIFFERENT DO
  • [5] [Anonymous], DIETARY REFERENCE IN
  • [6] Arabi A, 2016, OSTEOPOROS IN PRESS
  • [7] Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes
    Arabi, Asma
    El Rassi, Rola
    El-Hajj Fuleihan, Ghada
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (10) : 550 - 561
  • [8] Understanding heterogeneity in meta-analysis: the role of meta-regression
    Baker, W. L.
    White, C. Michael
    Cappelleri, J. C.
    Kluger, J.
    Coleman, C. I.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (10) : 1426 - 1434
  • [9] Genetic Variants in CYP2R1, CYP24A1, and VDR Modify the Efficacy of Vitamin D3 Supplementation for Increasing Serum 25-Hydroxyvitamin D Levels in a Randomized Controlled Trial
    Barry, Elizabeth L.
    Rees, Judy R.
    Peacock, Janet L.
    Mott, Leila A.
    Amos, Christopher I.
    Bostick, Roberd M.
    Figueiredo, Jane C.
    Ahnen, Dennis J.
    Bresalier, Robert S.
    Burke, Carol A.
    Baron, John A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (10) : E2133 - E2137
  • [10] Hypovitaminosis D in the Middle East and North Africa Prevalence, risk factors and impact on outcomes
    Bassil, Darina
    Rahme, Maya
    Hoteit, Maha
    Fuleihan, Ghada El-Hajj
    [J]. DERMATO-ENDOCRINOLOGY, 2013, 5 (02) : 274 - 298